{"id":2552,"date":"2018-08-02T14:10:59","date_gmt":"2018-08-02T12:10:59","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=2552"},"modified":"2020-10-07T19:56:03","modified_gmt":"2020-10-07T17:56:03","slug":"artios-pharma-announces-86-million-65-million-series-b-financing","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/","title":{"rendered":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing"},"content":{"rendered":"

\"\"<\/p>\n

 <\/p>\n

Cambridge, UK, 10 August 2018. <\/strong>Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer, today announced the completion of a $84 million (\u00a365 million) Series B financing following high interest from investors. The financing, which was significantly oversubscribed, was led by Andera Partners (formerly EdRIP) and LSP (Life Sciences Partners), with participation by additional new investors Pfizer Ventures and Novartis Venture Fund (NVF). Artios\u2019 existing shareholders Arix Bioscience, SV Health Investors, M Ventures, IP Group plc and AbbVie Ventures also participated in the fundraise.<\/p>\n

To read the full press release of Artios Pharma, click here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

  Cambridge, UK, 10 August 2018. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer, today announced the completion of a $84 million (\u00a365 million) Series B financing following high interest from investors. The financing, which was significantly oversubscribed, was led by Andera Partners (formerly EdRIP) and LSP…<\/p>\n","protected":false},"author":5,"featured_media":2546,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-2552","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"\nArtios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"  Cambridge, UK, 10 August 2018. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer, today announced the completion of a $84 million (\u00a365 million) Series B financing following high interest from investors. The financing, which was significantly oversubscribed, was led by Andera Partners (formerly EdRIP) and LSP...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2018-08-02T12:10:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-07T17:56:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"860\" \/>\n\t<meta property=\"og:image:height\" content=\"568\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stagiaire Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stagiaire Communication\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\"},\"author\":{\"name\":\"Stagiaire Communication\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8\"},\"headline\":\"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing\",\"datePublished\":\"2018-08-02T12:10:59+00:00\",\"dateModified\":\"2020-10-07T17:56:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\"},\"wordCount\":107,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg\",\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\",\"url\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\",\"name\":\"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg\",\"datePublished\":\"2018-08-02T12:10:59+00:00\",\"dateModified\":\"2020-10-07T17:56:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg\",\"width\":860,\"height\":568},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8\",\"name\":\"Stagiaire Communication\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g\",\"caption\":\"Stagiaire Communication\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/","og_locale":"en_US","og_type":"article","og_title":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS","og_description":"  Cambridge, UK, 10 August 2018. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer, today announced the completion of a $84 million (\u00a365 million) Series B financing following high interest from investors. The financing, which was significantly oversubscribed, was led by Andera Partners (formerly EdRIP) and LSP...","og_url":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2018-08-02T12:10:59+00:00","article_modified_time":"2020-10-07T17:56:03+00:00","og_image":[{"width":860,"height":568,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg","type":"image\/jpeg"}],"author":"Stagiaire Communication","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Stagiaire Communication"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/"},"author":{"name":"Stagiaire Communication","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8"},"headline":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing","datePublished":"2018-08-02T12:10:59+00:00","dateModified":"2020-10-07T17:56:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/"},"wordCount":107,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg","articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/","url":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/","name":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg","datePublished":"2018-08-02T12:10:59+00:00","dateModified":"2020-10-07T17:56:03+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/08\/DXgk65-X4AE4-H3.jpg","width":860,"height":568},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/en\/artios-pharma-announces-86-million-65-million-series-b-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"Artios Pharma Announces $86 million (\u00a365 million) Series B Financing"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/c00e4b2e37dad5476a07678494c723e8","name":"Stagiaire Communication","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b8fc49c2885cc8bd47fc12d37bdc253b?s=96&d=mm&r=g","caption":"Stagiaire Communication"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=2552"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/2552\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media\/2546"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=2552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=2552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}